The Institute of Medical Science, The University Of Tokyo

NEWS

2024.09.17

A paper by Norifumi Iijima, Sub-project Leader of Laboratory of Biofunctional Molecular Medicine (formerly Sub-project Leader of Laboratory of Adjuvant Innovation) of the National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), has been published in the European Journal of Immunology.

 

Tridecylcyclohexane in incomplete Freund’s adjuvant is a critical component in inducing experimental autoimmune diseases

Iijima N, Hayashi T, Niino M, Miyamoto Y, Oka M, Ishii KJ.
Eur J Immunol. 2024 Oct;54(10):e2350957. doi: 10.1002/eji.202350957.

Ishii's Laboratory

Division of Vaccine Science
The Institute of Medical Science, The University of Tokyo
4-6-1 Shirokanedai Minato-ku

vaccine★ims.u-tokyo.ac.jp※Please change ★ to @ and send